NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jenga Biosciences

Jenga Biosciences

Private
Carmel, IndianaHealthcare & Life Scienceshttps://www.jengabio.com/

Last Round

VC Round

Mar 1, 2024

Company Overview

Jenga Biosciences is a life sciences company that develops cancer treatments for veterinary use, specializing in pioneering immunotherapies for canine oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

canine oncologycanine immunotherapyveterinary biotherapeuticsimmuno-oncologyveterinary oncologycheckpoint inhibitoranimal health biotechanchored cytokine therapyinterleukin-12IL-12caninized monoclonal antibodyPD-1 inhibitorcompanion animal healthdrug developmentin-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jenga Biosciences Comps

Public and private peers based on sector, stage, and business model.

Jenga Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Jenga Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2024

Jenga Biosciences Investors

Notable investors and investment history

Jenga Biosciences investors
InvestorRounds
Borealis VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2024

    Round led by Borealis Ventures

Jenga Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jenga Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jenga Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarmel, Indiana
Employee Range3
Year Founded2024
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.